Ahmad Sadr
Corporate Officer/Principal bij APELLIS PHARMACEUTICALS, INC.
Profiel
Ahmad Sadr bekleedt de functie van Vice President-Technical Operations bij Apellis Pharmaceuticals, Inc. In het verleden bekleedde de heer Sadr de functie van Vice President-Technical Operations bij Vision Medicines, Inc. en Director-Outsourced Manufacturing bij Portola Pharmaceuticals, Inc. De heer Sadr is afgestudeerd aan de Widener University en heeft zijn doctoraal behaald aan de University of Maryland.
Actieve functies van Ahmad Sadr
| Bedrijven | Functie | Begin |
|---|---|---|
| APELLIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van Ahmad Sadr
| Bedrijven | Functie | Einde |
|---|---|---|
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2017 |
Vision Medicines, Inc.
 Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | 01-05-2016 |
Opleiding van Ahmad Sadr
| University of Maryland | Undergraduate Degree |
| Widener University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Vision Medicines, Inc.
Vision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Vision Medicines, Inc. operates as a clinical-stage biopharmaceutical company. It develops and commercializes therapies for patients suffering from blinding ocular diseases. The company was founded by Chris Varman and Reza Dana in May 2013 and is headquartered in Boston, MA. | Health Technology |
